Affymax

  www.affymax.com
Work in HR? Unlock Free Profile

8 Employee Reviews (View Most Recent)

Sort: Rating Date

 

Great opportunity for scientists and technicians

  • Comp & Benefits
  • Work/Life Balance
  • Senior Management
  • Culture & Values
  • Career Opportunities
Former Employee - Research Associate II  in  Mountain View, CA
Former Employee - Research Associate II in Mountain View, CA

Pros

Intellectually minded managers and supportive environment

Cons

Bought out by large pharma

Recommends
Positive Outlook
No opinion of CEO

Other reviews for Affymax

  1.  

    Great company work for

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Career Opportunities
    Former Employee - Research Associate  in  Palo Alto, CA
    Former Employee - Research Associate in Palo Alto, CA

    Pros

    Great benefit
    Friendly environment
    Effective communication with management

    Cons

    Not many projects work on

    Advice to ManagementAdvice

    Build more strong scientific teams

    Recommends
    Approves of CEO
  2.  

    Future for Affymax after Hematide is murky

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Career Opportunities
    Former Employee - Research Associate IV  in  Palo Alto, CA
    Former Employee - Research Associate IV in Palo Alto, CA

    Pros

    It has a peptide drug for anemia that is likely to be approved by the FDA. The drug has efficacy, low cost of goods, and is a good candidate for Medicare preference for the treatment of anemia for the dialysis patient population. The safety profile and monthly administration of the drug is a big advantage over the currently marketed drugs for anemia.

    Cons

    No more research for new targets for new drugs in the pipeline. All work was focused on the one drug; what is next? Unless a new target is identified, there isn't much for people at Affymax to do. They already laid off 95% of the researchers, so all that history and expertise is gone. It seems to be solely focused on getting Hematide through the trials, and now that they are ready to submit data to the FDA, what happens to anyone who isn't in sales and marketing?

    Advice to ManagementAdvice

    Sell the company to Takeda and make some money for the stockholders, or start up R&D again. The latest worry about cardiovascular effects really caused the stock to tank. Can it be explained, or are there changes that can be made in the administration of Hematide that would ameliorate that effect? Try some positive spin in the marketing approach.

    Approves of CEO
There are newer employer reviews for Affymax.

Worked for Affymax? Contribute to the Community!

Your response will be removed from the review – this cannot be undone.